Type:5ml drop
Generic Name:Betamethasone 0.1% E/E & Nasal prep
Manufacturer:Incepta Pharmaceuticals Ltd.
Price:৳30.00
Allergic and inflammatory conditions of the eye, ear & nose.
Adults Eye: 1 or 2 drops to each affected eye every 1 or 2 hours until control is achieved, then the frequency may be reduced. Ear: 2 or 3 drops to each affected ear every 2 or 3 hours until control is achieved, then the frequency may be reduced. Nose: 2 or 3 drops instilled into each nostril 2 or 3 times daily.
Children Eye: 1 or 2 drops to each affected eye every 1 or 2 hours until control is achieved, then the frequency may be reduced. Ear: 2 or 3 drops to each affected ear every 2 or 3 hours until control is achieved, then the frequency may be reduced. Nose: 2 or 3 drops instilled into each nostril 2 or 3 times daily.
Hypersensitivity; systemic fungal or acute infections.
Betamethasone is a corticosteroid with mainly glucocorticoid activity. It prevents and controls inflammation by controlling the rate of protein synthesis, depressing the migration of polymorphonuclear leukocytes and fibroblasts, and reversing capillary permeability and lysosomal stabilisation.
Uncontrolled diabetes, pregnancy and lactation. Elderly, regular monitoring of patients on long term therapy, withdraw gradually, glaucoma, hypothyroidism, ocular herpes simplex, infants and children.
Corneal ulcers, raised IOP and reduced visual acuity.
Increased hyperglycaemia and hypokalaemia with thiazide diuretics. Increased incidence of peptic ulcer or GI bleeding with concurrent NSAIDs admin. Response to anticoagulants altered. Dose of antidiabetics and antihypertensives needs to be increased. Decreases serum conc of salicylates and antimuscarinic agents. Potentially Fatal: Reduced efficacy with concurrent use of carbamazepine, phenytoin, primidone, barbiturates and rifampicin. Enhanced effect in women taking oestrogens or oral contraceptives.
